期刊文献+

38例肺动脉高压诊治体会

The experience of diagnosis of pulmonary hypertension in 38 cases
下载PDF
导出
摘要 目的探讨肺动脉高压患者的病因、临床表现、诊断和治疗,提高对肺动脉高压的认识与警惕性。方法对38例肺动脉高压患者的临床资料进行回顾性分析。结果肺动脉高压患者的发病原因、临床表现多种多样,97%的患者口服波生坦,62%的患者给予伊诺前列腺素(吸入或静点),48%的患者口服贝前列腺素等对症治疗,可取得良好的效果。氧饱和度升高了9.2%,肺动脉压力降低了9.4mm Hg。结论肺动脉高压的临床症状、体征不典型,误诊率高,需结合医技进行早期诊断,而早期治疗可提高患者的生存率。 Objective To explore the etiology of pulmonary hypertension patients, clinical manifestation, diagnosis and treatment, to improve the pulmonary artery high pressure understanding and vigilance. Methods The clinical data of Thirty-eight cases with pulmonary hypertension were retrospectively analyzed. Results The etiologies, clinical manifestation was varied in pulmonary artery hypertension patients, 97% of the patients oral Bosentan, 62% of the patients ino Prostaglandin (suction or static point), 48% of the patients oral Beraprost Sodium treatment, could get a good effect. Oxygen saturation increased 9.2%, pulmonary artery pressure dropped by 9.4 mm Hg. Conclusion The atypical clinical symptoms, signs not typical in pulmonary artery hypertension patients, the misdiagnosis rate is high, should be combined with medical for early diagnosis and early treatment can improve the survival rate of patients.
作者 王芙蓉 尹琦
出处 《中国当代医药》 2012年第32期188-189,共2页 China Modern Medicine
关键词 肺动脉高压 诊断 病因 临床表现 Pulmonary artery hypertension Diagnosis Cause Clinical manifestations
  • 相关文献

参考文献5

二级参考文献36

  • 1李淑秀,邓永莲.2型糖尿病肾病患者血浆可溶性内皮糖蛋白水平及意义[J].中国煤炭工业医学杂志,2020,23(1):104-108. 被引量:4
  • 2赵国忠.系统性硬皮病微循环和血液流变性改变与分析[J].微循环学杂志,1995,5(3):16-18. 被引量:8
  • 3Langevizy P, Buskila D, Gadman DD, et al. HLA alleles in systemic sclerosis:association with pulmonary hypertension and outcome. Br J Rheumatol, 1992, 31: 609-613.
  • 4British Cardiac Society Guidelines and Medical Practice Committee. Recommendations on the management of pulmonary hypertension in clinical practice. Heart, 2001, 86 Suppl 1:11-13.
  • 5Pan TL, Tlumboo J, Boey ML. Primary and secondary pulmonary hypertension in systemic lupus erythematosus. Lupus, 2000, 9: 338-342.
  • 6Christman BW, Mcpherson CD, Newman JH, et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med, 1992, 327: 70- 75.
  • 7Varga J. Pulmonary hypertension in systemic sclerosis. Curt Opin Rheumatol, 2002, 14: 666.
  • 8Ryan US. Receptors on pulmonary endothelial cells. Am Rev Repir Dis, 1990, 141: 464-469.
  • 9Denton CP, Cailes JB, Philips CD, et al. Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis. Br J Rheumatol, 1997, 36: 239-243.
  • 10Asbetson RA, Higchbottarn TW, Dinh-Xuan AT, et al. Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. J Rheumatol, 1990, 17: 1292-1298.

共引文献247

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部